Faculty Research Information |
Christine M. Albert, MD, MPH
Associate Physician, Brigham and Women’s Hospital
Associate Professor of Medicine, Harvard Medical School
Contact Information:
(p) 617-732-8784
(f) 617-731-3843
calbert@partners.org
Division of Preventive Medicine
Brigham and Women's Hospital
900 Commonwealth Avenue East, 3rd Floor
Boston, Massachusetts 02215
|
Dr. Albert is Associate Professor of Medicine at Harvard Medical School, and is an epidemiologist and a board-certified practicing clinical cardiac electrophysiologist with joint appointments in the Division of Preventive Medicine and the Cardiovascular Division at Brigham and Women’s Hospital. She serves as the Director of the Center for Arrhythmia Prevention. Dr. Albert’s research is centered on elucidating factors that predispose patients to sudden cardiac death and atrial fibrillation in lower risk populations enrolled in population-based epidemiologic investigations and in higher risk populations enrolled in multicenter clinical studies. In previous and ongoing work, Dr. Albert has examined the influence of dietary and lifestyle factors (e.g., n-3 fatty acids, trans-fatty acids, magnesium, alcohol), psychosocial factors (e.g., anxiety, depression), triggers (driving, anxiety, exercise) genetic markers (ion channel and beta-adrenergic receptor genes), and biomarkers (e.g., C-reactive protein, pro-BNP) on the risk of SCD and recurrent ventricular arrhythmias. She has recently extended this same methodology to the study of atrial fibrillation in two large prospective cohorts within the Division of Preventive Medicine.
Dr. Albert is currently the Principal Investigator of three NIH-sponsored studies: Genetic Determinants of Sudden Cardiac Death (R01HL068070), PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study (R01HL091069), and Modifiable Risk Factors for Ventricular Tachycardia (R21HL085741). In addition, Dr. Albert is the Principal Investigator of an industry-sponsored study, NT-Pro-Brain Natriuretic Peptide as a Predictor of Sudden Cardiac Death, and serves as Co-Investigator on several other studies. Through her expanding program of research, Dr. Albert has extensive experience in the design and conduct of epidemiologic investigations on sudden cardiac death, both in large cohort designs and within multi-center clinical studies.
Send Feedback to: 
